- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Thursday, 21 May 2015
-
Current Status:
Answered by Shona Robison on 3 June 2015
To ask the Scottish Government whether clinicians dealing with patients who have been referred by NHS Fife to services in NHS Tayside or Lothian can access the patient's (a) electronic clinical record other than by using the EMC or KIS systems and (b) laboratory results for tests carried out in NHS Fife.
Answer
Clinicians in NHS Lothian share a common clinical portal with NHS Fife and can access the information for NHS Fife patients via the clinical portal. NHS Tayside provide services to patients in NHS Fife in areas such as ear, nose and throat and vascular specialisms. Clinicians in NHS Fife can gain access to the NHS Tayside clinical portal if required. There are currently 196 NHS Fife clinicians who can access the NHS Tayside clinical portal. In addition, when NHS Tayside clinicians are involved in clinics in NHS Fife they can access the NHS Tayside clinical portal.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Thursday, 21 May 2015
-
Current Status:
Answered by Shona Robison on 3 June 2015
To ask the Scottish Government for what reason NHS contracts with TrakCare do not (a) ensure full continuity of access and (b) prevent possible interruption for up to several hours to access to clinically-important services when the contractor is carrying out updates.
Answer
NHS contracts with Trakcare do include penalties for any unscheduled downtime. NHSScotland is working with the Trakcare supplier to reduce downtime during upgrades which are scheduled. NHS boards will discuss updates with suppliers in advance and ensure that arrangements are in place to minimise any disruption. Scheduling of updates would be discussed and planned in advance with clinical teams to ensure that patient treatment or safety is not compromised.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Friday, 15 May 2015
-
Current Status:
Answered by Shona Robison on 2 June 2015
To ask the Scottish Government whether the Scottish Medicines Consortium (a) has considered or (b) will consider the use of bevacizumab in the treatment of wet macular degeneration.
Answer
Bevacizumab is not licensed in the UK for the treatment of wet macular degeneration. It is the remit of the Scottish Medicines Consortium to provide advice to NHSScotland on licensed medicines.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Tuesday, 26 May 2015
-
Current Status:
Taken in the Chamber on 26 May 2015
To ask the Scottish Government what action it has taken to ensure that the concerns of 56 doctors at the Beatson Cancer Centre regarding patient safety are fully addressed.
Answer
Taken in the Chamber on 26 May 2015
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 06 May 2015
-
Current Status:
Answered by Shona Robison on 14 May 2015
To ask the Scottish Government what its position is on introducing legislation to ensure that doctors who act on the basis of the evidence in a Cochrane Library review are protected from legal action.
Answer
I refer the member to the answer to question S4W-25434 on 14 May 2015 which is available on the Parliament’s website, the search facility for which can be found at:
http://www.scottish.parliament.uk/parliamentarybusiness/28877.aspx
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 06 May 2015
-
Current Status:
Answered by Shona Robison on 14 May 2015
To ask the Scottish Government what its position is on the Cochrane Library review, Systemic (whole body) safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration, which suggests that bevacizumab is an effective and less expensive alternative to ranibizumabin in the treatment of wet macular degeneration and, in light of this, whether it has asked the Scottish Medicines Consortium to consider authorising its use.
Answer
I refer the member to the answer to question S4W-25434 on 14 May 2015 which is available on the Parliament’s website, the search facility for which can be found at:
http://www.scottish.parliament.uk/parliamentarybusiness/28877.aspx
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 06 May 2015
-
Current Status:
Answered by Shona Robison on 14 May 2015
To ask the Scottish Government how much it has cost to treat wet macular degeneration with ranibizumabin in each of the last three years, and what information it has regarding how much it would have cost if bevacizumab had been used.
Answer
Bevacizumab is not licensed in the UK for the treatment of wet macular degeneration. Information on how much it has cost to treat wet macular degeneration with ranibizumab in each of the last three years and information on how much it would have cost if bevacizumab had been used is not held centrally. It is the remit of the Scottish Medicines Consortium to provide advice to NHSScotland on licensed medicines. The Scottish Government has noted the literature on the use of bevacizumab, and the position of the UK regulatory authorities, and has no plans to introduce legislation that would be outside the legislative competence of the Scottish Parliament.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 06 May 2015
-
Current Status:
Answered by Jamie Hepburn on 14 May 2015
To ask the Scottish Government what its position is on the reported increase in (a) diagnoses of disorders in young people that require both physical and mental health care and (b) the age range of those accessing paediatric services.
Answer
A definition of ‘diagnosis of disorder in young people that requires both physical and mental health care’ is not available nationally.
The national policy regarding age appropriate hospital care for children and young people was outlined in Better Health, Better Care: Hospital Services for Young People in Scotland, published on 5 May 2009. The report expects NHS boards to have well-structured transition arrangements that accord with best practice and to take advantage of the flexibility offered by the revised age limits to defer formal transfer to adult services until the most appropriate developmental stage for the young person.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Wednesday, 06 May 2015
-
Current Status:
Answered by Jamie Hepburn on 14 May 2015
To ask the Scottish Government how it ensures that paediatric inpatients can access appropriate multidisciplinary mental health care and treatment.
Answer
NHS boards should have in place procedures to ensure that mental health service link in to other services including paediatrics. Some health boards have mental health liaison services which can provide advice and support.
The Scottish Government committed £32 million over three years to improve priority specialist children’s services, as part of the National Delivery Plan: a three year plan (2009-11) with 55 commitments to enable improvement in priority specialist children’s services. Funding of £32 million was provided by the Scottish Government with recurring investment of £19.5 million from 2011-12 to ensure that services continue to improve, and this included funding from 2009-10 of £1 million recurring to Child and Adolescent Mental Health Services.
- Asked by: Dr Richard Simpson, MSP for Mid Scotland and Fife, Scottish Labour
-
Date lodged: Friday, 17 April 2015
-
Current Status:
Answered by Jamie Hepburn on 6 May 2015
To ask the Scottish Government what guidance it issues to ensure that equipment such as metal crutches, walking aids and braces is returned after use.
Answer
The Scottish Government issued Guidance on the Provision of Equipment and Adaptations in 2008. This guidance emphasises the importance of recycling community equipment. We have also published a report highlighting the benefits and savings to be made through effective recycling.
The Joint Improvement Team also continues to provide practical support and advice to partnerships on improving the procurement and delivery and recycling of community equipment.